Diabetes may worsen outcomes after esophageal cancer surgery, study finds
NCT ID NCT06333665
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 605 patients with esophageal cancer who had minimally invasive surgery to remove their esophagus. Researchers compared those with and without type 2 diabetes to see if diabetes affected short-term complications and long-term survival. The goal is to understand whether good diabetes control or metformin use might improve outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If it works, this could clarify whether managing diabetes before surgery improves long-term survival for esophageal cancer patients.
- What could go wrong
- This is an observational study, not a treatment trial, so it cannot prove cause and effect. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Army Medical Center of the People's Liberation Army
Chongqing, Chongqing Municipality, 400042, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new infusion drug shrink Hard-to-Treat tumors?
- Can a new drug combo shrink Hard-to-Treat tumors?
- Brain-Tracking anesthesia: a faster, smoother Wake-Up?
- Can robots make pediatric surgery safer? a new registry aims to find out
- Can big data reveal the true risks of lung surgery?
- Can a gas added to Heart-Lung machines shield Newborns' kidneys?